Welcome to LookChem.com Sign In|Join Free
  • or
1-(3-bromo-4-benzyloxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)heptan-3-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

936253-55-3

Post Buying Request

936253-55-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

936253-55-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 936253-55-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,2,5 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 936253-55:
(8*9)+(7*3)+(6*6)+(5*2)+(4*5)+(3*3)+(2*5)+(1*5)=183
183 % 10 = 3
So 936253-55-3 is a valid CAS Registry Number.

936253-55-3Relevant academic research and scientific papers

First total synthesis of cytotoxic diarylheptanoids, galeon, and pterocarine

Wang, Qian,Son, Jong-Keun,Jahng, Yurngdong

, p. 675 - 681 (2007)

The first total synthesis of cytotoxic diphenyl ether-type diarylheptanoids, galeon and pterocarine, was described in which the Ullmann reaction was employed at the final step for the diaryl ether formation of key intermediate, 1-(3-bromo-4-benzyloxypheny

Linear diarylheptanoids as potential anticancer therapeutics: synthesis, biological evaluation, and structure–activity relationship studies

Motiur Rahman,Lu, Yang,Lee, Hwa-Jong,Jo, Hyunji,Yin, Wencui,Alam, Mohammad Sayed,Cha, Hyochang,Kadi, Adnan A.,Kwon, Youngjoo,Jahng, Yurngdong

, p. 1 - 18 (2018/04/16)

In efforts to develop effective anticancer therapeutics with greater selectivity toward cancerous cell and reduced side-effects, such as emetic effects due to detrimental action of the drug toward the intestinal flora, a series of linear diarylheptanoids (LDHs) were designed and synthesized in 7 steps with good-to-moderate yields. All synthesized compounds were evaluated for their antibacterial, antiproliferative, and topoisomerase-I and -IIα inhibitory activity. Overall, all compounds showed little to no activity against the bacterial strains tested. Most of the synthesized compounds showed good antiproliferative activity against human breast cancer cell lines (T47D); specifically, the IC50 values of compounds 6a, 6d, 7j, and 7e were 0.09, 0.64, 0.67, and 0.99 μM, respectively. Among the tested compounds, 7b inhibited topo-I by 9.3% (camptothecin 68.8%), 7e and 7h inhibited topo-IIα by 38.4 and 47.4% (etoposide 76.9%), respectively, at the concentration of 100 μM. These results suggest that a set of promising anticancer agents can be obtained by reducing inhibitory actions on different microbes to provide enhanced selectivity against cancerous cells.

A versatile synthesis of cyclic diphenyl ether-type diarylheptanoids: Acerogenins, (±)-galeon, and (±)-pterocarine

Jeong, Byeong-Seon,Wang, Qian,Son, Jong-Keun,Jahng, Yurngdong

, p. 1338 - 1344 (2008/09/18)

A versatile method for the total synthesis of cyclic diphenyl ether-type diarylheptanoids, acerogenin C, acerogenin L, (±)-galeon, and (±)-pterocarine was described. The Ullmann reaction of suitably substituted linear diphenylheptanoids was employed for t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 936253-55-3